Veklury® (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content

A tétel rövid nézete
dc.contributor.authorKurtán Kitti
dc.contributor.authorDr. Kovács Tamás
dc.contributor.authorDr. Zákány Florina
dc.contributor.authorDr. Varga Zoltán
dc.contributor.authorDr. Panyi György
dc.contributor.authorDr. Nagy Péter
dc.contributor.departmentÁltalános Orvostudományi Karhu
dc.date.accessioned2023-06-22T21:09:59Z
dc.date.available2023-06-22T21:09:59Z
dc.date.issued2023-06
dc.identifier.urihttps://hdl.handle.net/2437/356510
dc.titleVeklury® (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content
Fájlok
Gyűjtemények
DETEP ÁOK